Skip to Content

P40 (Pantoprazole Sodium Delayed Release 40 mg)

Pill imprint P40 has been identified as Pantoprazole sodium delayed release 40 mg.

Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; erosive esophagitis; helicobacter pylori infection (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed release 40 mg P40
Pantoprazole sodium delayed release 40 mg P40  Front
Pantoprazole sodium delayed release 40 mg P40  Back
Pantoprazole sodium delayed release 40 mg P40
Pantoprazole sodium delayed release
Imprint:
P40
Strength:
40 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
ESI Lederle Generics
National Drug Code (NDC):
00008-0607
Inactive Ingredients:
calcium stearate
crospovidone
ferric oxide yellow
mannitol
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polysorbate 80
povidone k25
povidone k90
propylene glycol
sodium carbonate
sodium lauryl sulfate
titanium dioxide
triethyl citrate
hypromellose 2208 (100 mPa.s)

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide